NCT03879434View on ClinicalTrials.gov

Routine Application of Ostenil® Mini in Patients with Rhizarthrosis

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Rhizarthrosis
Interventions
DEVICE

Ostenil® Mini

Ostenil® Mini is a CE-certified viscoelastic solution for injection into the Joint cavity, containing 1.0 % sodium hyaluronate from fermentation

Trial Locations (6)

10711

Praxis für Orthopädie und Unfallchirurgie, Berlin

10789

Orthopädie am Tauentzien, Berlin

12555

MVZ Berlin Freiheit 1, Berlin

13589

Orthopädie am Kiesteich, Berlin

14052

Wirbelsäulen Gelenk Zentrum Westend, Berlin

14109

Orthopädie Wannsee, Berlin

All Listed Sponsors
lead

TRB Chemedica AG

INDUSTRY

NCT03879434 - Routine Application of Ostenil® Mini in Patients with Rhizarthrosis | Biotech Hunter | Biotech Hunter